Modular Medical, Inc. (NASDAQ:MODD – Get Free Report) CEO Manchester Management Co Llc purchased 10,000 shares of the business’s stock in a transaction on Thursday, November 19th. The stock was bought at an average cost of $2.03 per share, for a total transaction of $20,300.00. Following the purchase, the chief executive officer owned 24,067 shares of the company’s stock, valued at approximately $48,856.01. This represents a 71.09% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Modular Medical Stock Down 11.1%
Modular Medical stock opened at $1.69 on Friday. The stock has a market capitalization of $16.05 million, a PE ratio of -0.19 and a beta of 0.52. Modular Medical, Inc. has a twelve month low of $1.20 and a twelve month high of $16.20. The company has a 50 day moving average of $2.02 and a 200-day moving average of $4.43.
Modular Medical (NASDAQ:MODD – Get Free Report) last issued its quarterly earnings data on Monday, November 16th. The company reported ($0.90) EPS for the quarter.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on MODD shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Modular Medical in a report on Monday, September 21st. Wall Street Zen upgraded Modular Medical from a “strong sell” rating to a “sell” rating in a report on Sunday, August 23rd. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, Modular Medical currently has an average rating of “Sell”.
View Our Latest Stock Report on Modular Medical
Hedge Funds Weigh In On Modular Medical
An institutional investor recently raised its stake in Modular Medical stock. AWM Investment Company Inc. raised its holdings in shares of Modular Medical, Inc. (NASDAQ:MODD – Free Report) by 20.3% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 441,095 shares of the company’s stock after acquiring an additional 74,429 shares during the quarter. AWM Investment Company Inc. owned approximately 7.38% of Modular Medical worth $1,985,000 at the end of the most recent reporting period. 27.47% of the stock is owned by hedge funds and other institutional investors.
Modular Medical Company Profile
Modular Medical, Inc. is a medical-device company focused on developing insulin-delivery technology for people with diabetes. Its work centers on making pump therapy simpler and more accessible for people who may find traditional insulin pumps difficult to use. The company’s lead product, MODD1, is a wearable insulin-delivery system designed to provide an alternative to multiple daily insulin injections. Modular Medical describes the device as a simplified pump intended to make insulin delivery easier to manage.
Featured Articles
- Five stocks we like better than Modular Medical
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.
